Skip to content
Search

Latest Stories

Community pharmacy key to neighbourhood health, but investment needed, says CCA chief

Think-tank Reform emphasises that community pharmacies are more likely to be situated in areas of high deprivation and see patients more than anyone else in the primary care system.

Community pharmacy needs investment and support to deliver neighbourhood health, says CCA chief

Community pharmacies see patients more than anyone else in the primary care system.

Getty Images

Community pharmacies can play a vital role in delivering a ‘neighbourhood health service’, provided they receive the necessary investment and support, according to Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA).

Harrison's comments come in response to a new report from think tank Reform, titled Designing a Neighbourhood Health Service, which outlines key principles for achieving the government's vision of a more community-focused healthcare system.


The report highlighted the significant contribution that community pharmacies can make in shifting care away from hospitals and into local communities.

“To be effective, Neighbourhood Health must be grounded in close partnership between health providers in a local area, but also between community leaders and the full breadth of organisations that operate at this scale, and which have a strong understanding of their communities: including local authorities, pharmacies, faith groups, local businesses and the VCFSE sector,” the report said.

The report emphasised the accessibility and reach of community pharmacies, particularly in areas of high deprivation.

It noted that over 93 per cent of patients living in areas of highest deprivation live within a mile of a pharmacy, compared to 71 per cent in areas of lowest deprivation.

Furthermore, the report emphasised that high street healthcare providers, such as community pharmacies, are more likely to employ practitioners who “reflect the demographics of the communities they serve” and see patients “more than anyone else in the primary care system (e.g. through their retail offer and unplanned drop-ins).”

“The median number of visits to a pharmacy is much higher, on average, than the median number of visits to general practice each year,” it stated.

Harnessing community pharmacy

Harrison welcomed the report as a timely recognition of “the huge potential to harness community pharmacy to deliver effective neighbourhood health.”

“With more pharmacies in more deprived communities, a workforce typically drawn from nearby neighbourhoods and highly trusted by patients, the community pharmacy network is ideally placed to improve health outcomes,” he said.

The government has set plans to move care closer to the community and shift from treating sickness to preventing ill health.

Harrison urged the Department of Health and NHS England to adopt the report’s proposed “actionable steps” to realise these shifts and provide pharmacies with the investment and backing they need to fulfil their role in a Neighbourhood Health Service.

Challenges

The report also acknowledged key challenges in delivering a truly integrated neighbourhood health system.

One major issue is data sharing between different healthcare providers.

The report noted that in many parts of the health system, there are “long-standing challenges around data controllership and how data is shared between organisations – particularly general practice and other providers of primary care like community pharmacy, optometry, audiology and dentistry.”

“Whilst GPs currently have controllership of data, it is imperative that other partners within primary care can also use data to support and configure services around population groups,” the report noted.

For example, the report cited a project where loyalty card data was used to predict women at risk of ovarian cancer. Early results suggested that analysis of shopping habits at pharmacies and supermarkets could indicate early warning signs often missed by GPs.

“This example demonstrates that the places which individuals have frequent contact with, such as the local supermarket and pharmacy, may have the data and knowledge of their users which can be applied to improve health outcomes,” it added.

The report argued that current neighbourhood-level health strategies are dominated by Primary Care Networks, which tend to take a “top-down and GP-led approach”, to the detriment of other primary care practitioners, such as dentists, pharmacists, audiologists and optometrists, as well as other organisations which contribute to population health at this level.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less